Meindert Boysen

Centre for Health Technology Evaluation, NICE

Meindert is the Director of the Centre for Health Technology Evaluation at the National Institute for Health and Care Excellence (NICE). He was previously responsible for running NICE’s technology appraisal and highly specialised technologies programmes, Meindert has a strong track record in health technology evaluation, occupying a senior technical and leadership role in NICE’s drug appraisal programme. Before joining NICE in 2004 Meindert worked for Eli Lilly in the Netherlands, and for the King’s Fund in London after graduating with an MSc in Health Policy Planning and Financing from the London School of Economics & Political Sciences. Meindert was previously on the Board of Directors for The International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 2017 – 2020.